Non-invasive biomarkers and scoring systems show strong capability in differentiating chronic liver disease from cirrhosis, ...

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...

Global research into the gut microbiome has exploded over the past decade, with most of the spotlight shining on the complex, ...

Fatty liver disease, also known as Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), is a chronic liver ...

To test their new drug, the researchers conducted experiments on mice that were fed a high-fat diet, which typically leads to ...

Pregnant women with metabolic dysfunction-associated steatotic liver disease (MASLD) have an increased risk of giving birth prematurely and the risk increase cannot be explained by obesity, according ...

Distinct trends were seen in etiology-based mortality with chronic liver disease (CLD) before, during, and after the COVID-19 ...

An experimental new treatment is showing early promise in the fight against liver fibrosis – a serious and often silent ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

Learn 8 tips to enhance your livers natural detoxification abilities, protect against damage, and support metabolic health through diet and lifestyle changes.

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...